Use of WHO paediatric weight-band dosing in drug labels
- PMID: 34883067
- DOI: 10.1016/S2352-3018(21)00277-0
Use of WHO paediatric weight-band dosing in drug labels
Conflict of interest statement
AC has received honoraria from Merck Sharp and Dohme, paid to the institution; and trial grants from ViiV Healthcare, Gilead, and Merck, paid to the institution. TGJ and HW declare no competing interests.
Comment on
-
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study.Lancet HIV. 2022 Jan;9(1):e24-e31. doi: 10.1016/S2352-3018(21)00266-6. Epub 2021 Dec 6. Lancet HIV. 2022. PMID: 34883066 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical